Scientists map fat and organelles in breast cancer cells to unlock subtype secrets

NCT ID NCT07233928

Recruiting now Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is collecting tumor samples from 1,050 people with early or metastatic breast cancer to analyze fat storage and organelle properties in cancer cells. Researchers aim to create a detailed atlas of these features across different breast cancer subtypes. The goal is to better understand the biology of each subtype, which may inform future research and treatment approaches.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help researchers better understand how breast cancer subtypes differ at the cellular level, potentially guiding future treatments.
What could go wrong: This is an observational study, not a treatment trial. It will not directly benefit participants and may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm HER2 positive breast carcinoma luminal A breast carcinoma luminal B breast carcinoma triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EARLY BREAST CANCER METASTATIC BREAST CANCER

Contacts and locations

Locations

Institut Universitaire du Cancer de Toulouse - Oncopole
RECRUITING

Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.